RLYB vs MXCT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RLYB Captures Institutional Edge (2โ2 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Rallybio Corporation Common Stock (RLYB) driven by superior Valuation, Momentum & Technical while MXCT counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, RLYB trades at N/M Forward P/E with -5050.9% operating margin (+0.0% YoY revenue) versus MXCT at N/M Forward P/E and -85.5% operating margin (+48.7% YoY). In options structure, RLYB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RLYB Revenue | MXCT Revenue | RLYB Op. Margin | MXCT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $10M | N/A | -93.7% | MXCT |
| FY2020 | N/A | $20M | N/A | -71.6% | MXCT |
| FY2021 | N/A | $20M | N/A | -84.3% | MXCT |
| FY2022 | N/A | $30M | N/A | -95.2% | MXCT |
| FY2023 | N/A | $20M | N/A | -247.7% | MXCT |
| FY2024 | $0M | $20M | -9511.9% | -230.5% | MXCT |
| FY2025 | $0M | $20M | -3853.6% | -247.6% | MXCT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RLYB | MXCT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $86.9M | $132.2M | Larger Scale | MXCT |
| Trailing P/E Ratio Valuation | 3.4x | N/M | Lower Multiple | RLYB |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +48.7% | Higher Growth | MXCT |
| Operating Margin (TTM) Profitability | -5050.9% | -85.5% | Higher Margin | MXCT |
| Net Profit Margin Profitability | 6177.4% | -81.4% | Higher Margin | RLYB |
| Return on Equity (ROE) Capital Efficiency | 34.5% | -16.9% | Higher ROE | RLYB |
| 52-Week Range Position Momentum | 88% ($1โ$18) | 63% ($1โ$2) | Stronger Trend | RLYB |
| Beta / 30D Volatility Risk Regime | 0.37ฮฒ ยท 24% Vol | 1.19ฮฒ ยท 96% Vol | Lower Realized Risk | RLYB |
| Unified Institutional Score Composite Signal | 63.0 / 100 (BUY) | 41.7 / 100 (SELL) | Higher Composite | RLYB |